Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alison C West

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Current Pharmaceutical Design|May 26, 2015
Inflammatory and non-inflammatory roles for Toll-like receptors in gastrointestinal cancerAlison C West, Brendan J Jenkins
The Journal of Clinical Investigation|January 3, 2014
New and emerging HDAC inhibitors for cancer treatmentAlison C West, Ricky W Johnstone
Methods in Molecular Biology (Clifton, N.J.)|January 25, 2016
Investigating the Role of Toll-Like Receptors in Mouse Models of Gastric CancerAlison C West, Brendan J Jenkins
Oncoimmunology|April 5, 2014
The anticancer effects of HDAC inhibitors require the immune systemAlison C West, Mark J Smyth, Ricky W Johnstone
Oncoimmunology|June 28, 2012
The combination of histone deacetylase inhibitors with immune-stimulating antibodies has potent anti-cancer effectsAlison C West, Ailsa J Christiansen, Mark J Smyth, et al.
Viruses|February 27, 2026
Dissecting Cell Death Pathways in Influenza A Virus Infection: Comparative Insights from Human ModelsNgoc Mai Khoi Nguyen, Alison C West, Rebecca L Ambrose, et al.
Frontiers in Oncology|March 18, 2022
Inflammasome-Associated Gastric Tumorigenesis Is Independent of the NLRP3 Pattern Recognition ReceptorAlice J West, Virginie Deswaerte, Alison C West, et al.
Particle and Fibre Toxicology|May 3, 2026
Epithelial NLRP3 drives silica-induced lung injury and fibrosis through IL-18 and pro-fibrotic neutrophil recruitmentMaggie Lam, Kristian T Barry, Christopher J Hodges, et al.
Cell Death & Disease|November 9, 2023
Gasdermin D promotes hyperinflammation and immunopathology during severe influenza A virus infectionSarah Rosli, Christopher M Harpur, Maggie Lam, et al.
Cancer Research|October 26, 2013
An intact immune system is required for the anticancer activities of histone deacetylase inhibitorsAlison C West, Stephen R Mattarollo, Jake Shortt, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Current Pharmaceutical Design|May 26, 2015
Inflammatory and non-inflammatory roles for Toll-like receptors in gastrointestinal cancerAlison C West, Brendan J Jenkins
The Journal of Clinical Investigation|January 3, 2014
New and emerging HDAC inhibitors for cancer treatmentAlison C West, Ricky W Johnstone
Methods in Molecular Biology (Clifton, N.J.)|January 25, 2016
Investigating the Role of Toll-Like Receptors in Mouse Models of Gastric CancerAlison C West, Brendan J Jenkins
Oncoimmunology|April 5, 2014
The anticancer effects of HDAC inhibitors require the immune systemAlison C West, Mark J Smyth, Ricky W Johnstone
Oncoimmunology|June 28, 2012
The combination of histone deacetylase inhibitors with immune-stimulating antibodies has potent anti-cancer effectsAlison C West, Ailsa J Christiansen, Mark J Smyth, et al.
Viruses|February 27, 2026
Dissecting Cell Death Pathways in Influenza A Virus Infection: Comparative Insights from Human ModelsNgoc Mai Khoi Nguyen, Alison C West, Rebecca L Ambrose, et al.
Frontiers in Oncology|March 18, 2022
Inflammasome-Associated Gastric Tumorigenesis Is Independent of the NLRP3 Pattern Recognition ReceptorAlice J West, Virginie Deswaerte, Alison C West, et al.
Particle and Fibre Toxicology|May 3, 2026
Epithelial NLRP3 drives silica-induced lung injury and fibrosis through IL-18 and pro-fibrotic neutrophil recruitmentMaggie Lam, Kristian T Barry, Christopher J Hodges, et al.
Cell Death & Disease|November 9, 2023
Gasdermin D promotes hyperinflammation and immunopathology during severe influenza A virus infectionSarah Rosli, Christopher M Harpur, Maggie Lam, et al.
Cancer Research|October 26, 2013
An intact immune system is required for the anticancer activities of histone deacetylase inhibitorsAlison C West, Stephen R Mattarollo, Jake Shortt, et al.
Pageof 3